FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Isomeric Pharmacy Solution Methylprednisolone Acetate/Lidocaine HCl Recall

Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial…

Isomeric Pharmacy Solution, LLC · Salt Lake City, UT

Risk level
Class II
Reported by FDA
Sep 14, 2016
Recall ID
D-1480-2016
Check your lot numberHow we source this data

Summary

Isomeric Pharmacy Solution recalled Methylprednisolone Acetate/Lidocaine HCl starting Jun 29, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1480-2016 on Sep 14, 2016. Reason: Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles. Status: Terminated.

Why it was recalled

Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.

Product description

Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial, sterile. Rx only. Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109,

Lot numbers, UPCs & expiration codes

Lots# 03045 and 03046; Exp. 10/16

Where it was sold

Nationwide and Puerto Rico. No Canadian, other foreign, govt/VA/military consignees.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1480-2016
Classification
Class II
Status
Terminated
Recall initiated
Jun 29, 2016
FDA report date
Sep 14, 2016
Quantity
274 multdose vials
Recall type
Voluntary: Firm initiated
Recalling firm
Isomeric Pharmacy Solution, LLC

Original FDA data

Every field from FDA enforcement report D-1480-2016, exactly as published.

Show all FDA fields
City
Salt Lake City
State
UT
Status
Terminated
Country
United States
Event ID
74603
Address
2401 S Foothill Dr
Code information
Lots# 03045 and 03046; Exp. 10/16
Postal code
84109-1479
Report date
Sep 14, 2016
Product type
Drugs
Recall number
D-1480-2016
Classification
Class II
Recalling firm
Isomeric Pharmacy Solution, LLC
Product quantity
274 multdose vials
Termination date
Dec 20, 2016
Reason for recall
Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial, sterile. Rx only. Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109,
Distribution pattern
Nationwide and Puerto Rico. No Canadian, other foreign, govt/VA/military consignees.
Recall initiation date
Jun 29, 2016
Initial firm notification
Letter
Center classification date
Sep 2, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1480-2016, published Sep 14, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls